SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Far below the surface, where light no longer reaches and noise collapses into silence, the Sperm Whale endures.  It does not rely on speed or spectacle. It survives through mass, intelligence, and absolute awareness of its surroundings.  This project is shaped by the same principle — strength formed under pressure, movement guided by understanding, and conviction built where others cannot remain.  While the surface reacts, the deep decides.

The Sperm Whale

SPERMWHALE is driving intense community activity and speculative buying as traders anticipate a potential breakout and further price discovery. While some market participants express caution regarding volatility and project longevity, the active community remains focused on momentum and the potential for the stock to surpass previous highs.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics is currently trending following the announcement of a preliminary Phase 3 trial design for its lead candidate, CAD-1005, aimed at treating Heparin-Induced Thrombocytopenia. Investors are actively debating the company's clinical prospects and reliance on event-driven catalysts, while some community members voice concerns over potential dilution risks and the influence of automated social media activity.

ProShares Trust - ProShares Ultra Semiconductors 2X Shares

ProShares Ultra Semiconductors

The ProShares Ultra Semiconductors ETF ($USD) is capturing significant investor attention as momentum in the semiconductor sector remains robust, with traders actively debating whether to scale into the fund to capitalize on the continued growth of high-performance AI hardware. Community sentiment is currently driven by the fund's leveraged exposure to industry leaders, leading to intense discussions regarding technical entry points, re-accumulation strategies during market volatility, and the fund's historical performance relative to broader technology-linked ETFs.

SPDR Series Trust - State Street SPDR S&P Biotech ETF

SPDR S&P Biotech ETF

The SPDR S&P Biotech ETF (XBI) is trending due to a wave of high-value M&A activity and positive data readouts that are fueling optimism across the sector. Investors are actively discussing the potential for sector re-ratings, with many community members highlighting specific oncology and pipeline assets as undervalued opportunities for long-term growth.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth is trending on the back of a major $2.8 billion acquisition of the Serra Verde Group, a move widely discussed by the community as a strategic step toward building an end-to-end U.S. supply chain for critical magnets. Investors are closely monitoring the resulting volatility and share dilution implications, while technical analysts debate the sustainability of the recent breakout as interest in rare earth stocks remains heightened by ongoing geopolitical supply concerns.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. It operates through the Steelmaking and Other Businesses segments. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs is trending as investors debate its long-term industrial value against ongoing volatility, fueled by active community discussion regarding a potential strategic partnership with POSCO and the company's role in the domestic infrastructure supply chain. Traders are closely monitoring the stock's technical support levels and high short interest, weighing the impact of fluctuating commodity prices and sector-specific catalysts against concerns over the company's debt profile and leadership.

Chipotle Mexican Grill, Inc. engages in the business of developing and operating restaurants that serve a relevant menu of burritos, burrito bowls, quesadillas, tacos, and salads made using fresh, high-quality ingredients. The company was founded by Steve Ells in 1993 and is headquartered in Newport Beach, CA.

Chipotle Mexican Grill

Chipotle Mexican Grill is facing intense investor frustration as the stock struggles with downward pressure despite recent earnings efforts and expansion plans. The community is actively debating the effectiveness of current leadership and management strategies, frequently comparing the brand's lackluster performance and service quality to more agile competitors in the fast-casual sector.

Schwab Strategic Trust - Schwab US Dividend Equity ETF

Schwab US Dividend Equity ETF

Schwab US Dividend Equity ETF is trending as investors rotate toward defensive, dividend-focused assets, viewing the fund as a stable "anchor" amidst broader market volatility. The community is actively discussing the ETF's resilience on red market days, with long-term holders emphasizing the power of compounding dividends and reliable cash flow over high-growth speculative plays.

Citigroup Global Markets Holdings, Inc. provides investment banking and securities brokerage services. It offers financial advisory, research and capital raising services to corporations, governments and individuals. The company was founded in 1977 and is headquartered in New York, NY.

Citigroup Inc

Citigroup Inc. is trending as it hits fresh 52-week highs, driven by strong institutional momentum, consistent corporate buybacks, and investor optimism surrounding its multi-year strategic transformation under CEO Jane Fraser. The community is actively debating the sustainability of this parabolic rally, weighing the bank's improved operational efficiency and capital strength against concerns that the rapid price ascent may be overextended.

Elicio Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of cancer immunotherapies. It focuses on its Amphiphile platform for trafficking lymph nodes. The company was founded by Darrell Irvine in August 2011 and is headquartered in Boston, MA.

Elicio Therapeutics Inc.

Elicio Therapeutics Inc

Elicio Therapeutics is trending as investors focus on the company's progress with ELI-002, a cancer vaccine candidate targeting KRAS-mutant solid tumors, while discussing potential risks related to cash runway and future financing needs. Community sentiment remains split between excitement over strong preliminary clinical data and concerns regarding the necessity of capital raises or dilution to fund upcoming phase 3 trials.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Capital City Bank Group (NASDAQ:CCBG) Downgraded by Wall Street Zen to "Sell"

Wall Street Zen lowered Capital City Bank Group from a "hold" rating to a "sell" rating in a research report on Sunday...

Capital City Bank Group (NASDAQ:CCBG) Stock Rating Upgraded by Wall Street Zen

Wall Street Zen upgraded Capital City Bank Group from a "sell" rating to a "hold" rating in a research report on Saturday...

Capital City Bank (CCBG) Upgraded to Buy: Here's What You Should Know

Capital City Bank (CCBG) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Why Capital City Bank (CCBG) is a Great Dividend Stock Right Now

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Capital City Bank (CCBG) have what it takes? Let's find out.

Capital City Bank Group (NASDAQ:CCBG) Given New $50.00 Price Target at Keefe, Bruyette & Woods

Keefe, Bruyette & Woods raised their price target on Capital City Bank Group from $45.00 to $50.00 and gave the stock a "market perform" rating in a research note on Tuesday...

Capital City Bank Group (NASDAQ:CCBG) Downgraded by Brean Capital to "Neutral"

Brean Capital lowered Capital City Bank Group from a "buy" rating to a "neutral" rating in a report on Tuesday...

Capital City Bank Group (NASDAQ:CCBG) Posts Quarterly Earnings Results, Beats Estimates By $0.09 EPS

Capital City Bank Group (NASDAQ:CCBG - Get Free Report) announced its quarterly earnings data on Monday. The financial services provider reported $0.92 earnings per share (EPS) for the quarter...

Capital City Bank (CCBG) Tops Q1 Earnings Estimates

Capital City Bank (CCBG) delivered earnings and revenue surprises of +8.24% and -1.18%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Capital City Bank Group Inc. Q1 Profit Retreats

(RTTNews) - Capital City Bank Group Inc. (CCBG) announced a profit for first quarter that Dropped, from last year...

Capital City Bank Group (NASDAQ:CCBG) Sets New 12-Month High - Here's What Happened

Capital City Bank Group (NASDAQ:CCBG) Sets New 12-Month High - Should You Buy...

Capital City Bank Group, Inc. operates as a bank holding company. Its principal services are Banking Services, Trust and Asset Management Services, and Brokerage Services. The firm provides traditional deposit and credit services, mortgage banking, asset management, trust, merchant services, bank cards, data processing and securities brokerage services. The company was founded on December 13, 1982 and is headquartered in Tallahassee, FL.

Current Price	$46.57
Prev Close	$46.17
Open	$46.20
Dividend Yield	2.35%
50-Day Moving Average	$44.18
Beta	0.68
Avg. Volume	97,132.22
PE Ratio	13.18

52-Week High	$48.78
52-Week Low	$35.72
Market Capitalization	$796.41M
EPS (Annual)	$3.60
Price to Book	1.36
Revenue Per Employee	$322,498.89

CCBG
Capital City Bank Group, Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CCBG News

CCBGCapital City Bank Group, Inc.